Evotec SE (EVT MU) stock market data APIs
€7.1586
0(0%)
as of October 28, 2025
Try our APIs with
free plan!
Evotec SE Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for EVT.MU.
Prev. Close
7.1586
Open
7.1586
High
7.1586
Low
7.1586
52 wk Range
5.17-10.54
Market Cap
7 158 M
EPS
-0.22
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Evotec SE data using free add-ons & libraries
Get Evotec SE Fundamental Data
Evotec SE Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2024-11-06
- EPS/Forecast: -0.11
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Evotec SE News
New
Evaluating Evotec (XTRA:EVT): Exploring Valuation After Recent Share Price Surge
Evotec (XTRA:EVT) shares have caught the attention of investors following recent price swings over the past month, seeing a gain of nearly 19%. Given the volatility of the biotech sector, investors ar...
Evotec Announces Progress in Preclinical Neuroscience Partnership with Bristol Myers Squibb
Advances made in preclinical pipeline addressing neurodegenerative diseases Evotec receives US$ 25 m payment to support continued progression of joint programs HAMBURG, DE / ACCESS Newswire / October...
ESPR Aims to Diversify With Rare Liver Disease Candidate, Stock Up
Esperion Therapeutics ESPR announced that it has nominated ESP-2001, a highly specific allosteric ATP citrate lyase (“ACLY”) inhibitor, as its new preclinical development candidate for the treatme...
FairJourney Biologics Appoints Dr. Werner Lanthaler as Chief Executive Officer
Dr. Werner Lanthaler will strengthen FairJourney Biologics’ global position as a highly efficient partner for antibody discovery and development Founder António Parada will focus on innovation stra...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
